Day By Day - NMC Health PLC (NMC) Analyse court terme - NMC HEALTH PLC : Les cours progressent toujours.

Report

Day By Day

Matthieu DRIOL

EUR 112.50 For Business Accounts Only

Analyse court terme - NMC HEALTH PLC : Les cours progressent toujours.

La tendance de fond est clairement orientÃ©e Ã la hausse. Les cours progressent toujours.
Les objectifs suivants sont Ã 3Â 844,19 p et 4Â 210,10 p. La tendance serait invalidÃ©e sous le support Ã 3Â 254,31 p.

23/07/2018 1 FR

Underlying

NMC Health PLC

See profile

GB00B7FC0762 United Kingdom

Provider

Day By Day

DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.

See profile

Analysts

Matthieu DRIOL

Other Reports on these Companies

Independent Investment Research

Monthly LMI Update Independent Investment Research

Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked. This compares to the total dividends of 5 cents per share in FY20. The Board has confirmed that, in...

August 6, 2021 August 6, 2021 10 EN

SmartInsider

NMC Health: 1 director sold

A director at NMC Health sold 10,900,000 shares at 1,026p and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board me...

Free Trial

March 4, 2020 March 4, 2020 1 EN

EQS Group AG

Form 8.3 - The Vanguard Group, Inc.: NMC Health plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: NMC Health plc 28-Feb-2020 / 14:08 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. FORM 8.3 Â PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") Â 1.Â KEY INFORMATION Â (a)Â Full name of discloser: The Vanguard Group, Inc. (b)Â Owner or controller of interests a...

February 28, 2020 February 28, 2020 1 EN

Short term view - GBP-CHF : The major resistance is close.

The trend remains neutral. Prices will have to break above the peak at CHF 1.3104 for the trend to be positive again with an invalidation level below CHF 1.2740.Arguments :- The major resistance is close.- The moving average is capping prices.

EUR 112.50

November 2, 2018 November 2, 2018 1 EN

Valérie GASTALDY

Valérie GASTALDY

La tendance est toujours neutre. Il faut franchir le sommet Ã 1,3104 CHF pour que la tendance devienne positive avec une invalidation sous 1,2740 CHF.Arguments :- La rÃ©sistance majeure est proche.- La moyenne mobile sert de rÃ©sistance.

EUR 112.50

November 2, 2018 November 2, 2018 1 FR

Valérie GASTALDY

Valérie GASTALDY

Short term view - GBP-USD : Pull-back

The trend is momentarily interrupted by a consolidation on a shorter time horizon but prices remain below the invalidation level at $1.3210. It can resume at anytime towards the target at $1.2600.Arguments :- Prices are pulling back to the major resistance level (previously a support). The fall will resume afterwards.- The falling moving average confirms our opinion.

EUR 112.50

November 2, 2018 November 2, 2018 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Analyse court terme - NMC HEALTH PLC : Les cours progressent toujours.

Monthly LMI Update Independent Investment Research

NMC Health: 1 director sold

Form 8.3 - The Vanguard Group, Inc.: NMC Health plc

Short term view - GBP-CHF : The major resistance is close.

Analyse court terme - GBP-CHF : La rÃ©sistance majeure est proche.

Short term view - GBP-USD : Pull-back

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe